Skip to main content
. 2021 Dec 23;16:8309–8321. doi: 10.2147/IJN.S331909

Figure 10.

Figure 10

Changes in the MMP of the HepG2 cell line following treatments with the prepared nanoformulations compared to untreated cells as estimated by flow cytometric analysis.